Similar articles

• [Primary treatment of acute promyelocytic leukemia using all-trans-retinoic acid].

  Leeksma OC, van Oers MH, van der Schoot CE, Goudsmit R, von dem Borne AE. Leeksma OC, et al. Ned Tijdschr Geneeskd. 1993 Apr 17;137(16):821-5. Ned Tijdschr Geneeskd. 1993. PMID: 8487886 Dutch.
• Update on the management of pediatric acute promyelocytic leukemia.

  Ribeiro R. Ribeiro R. Clin Adv Hematol Oncol. 2006 Apr;4(4):263-5. Clin Adv Hematol Oncol. 2006. PMID: 16728936 Review. No abstract available.
• Biology and treatment of acute promyelocytic leukemia.

  Fenaux P, Chomienne C. Fenaux P, et al. Curr Opin Oncol. 1996 Jan;8(1):3-12. doi: 10.1097/00001622-199601000-00002. Curr Opin Oncol. 1996. PMID: 8868093 Review.
• Acute promyelocytic leukaemia. Report of a meeting of Physicians and Scientists, University College London.

  [No authors listed] [No authors listed] Lancet. 1994 Dec 10;344(8937):1615-8. Lancet. 1994. PMID: 7983997 No abstract available.
• JSH practical guidelines for hematological malignancies, 2018: I. Leukemia-2. Acute promyelocytic leukemia (APL).

  Fujita H, Ishikawa Y, Yokoyama Y. Fujita H, et al. Int J Hematol. 2020 Jun;111(6):747-760. doi: 10.1007/s12185-020-02884-z. Epub 2020 Apr 28. Int J Hematol. 2020. PMID: 32347422 No abstract available.